Advanced Diagnostic Solutions

Industry-Leading Laboratory Technologies and Services

AccessDx Laboratory provides advanced diagnostic solutions for personalized medicine, infectious disease programs, and COVID-19 testing. AccessDx Laboratory technologies include advanced molecular diagnostics platforms, next generation sequencing capabilities, and high throughput sample processing capabilities. AccessDx Lab has proven its expertise and the scalability of its platforms for thousands of client groups including large national health systems, municipalities, long-term care organizations, employers, pharmacists, and providers.

COVID-19 Diagnostic Solutions

COVID-19 testing cover

COVID-19 PCR Test

PCR-based testing remains the gold standard for the identification of current infections in both symptomatic and asymptomatic individuals. AccessDx provides high-quality clinical-grade RT-PCR tests that are compliant with the FDA’s in-effect policy guidance for COVID-19 testing performed by CLIA-certified laboratories.

Download the PDF

COVID-19 Flu Combo PCR Test

The AccessDx COVID-19 + Flu Combo test is a combined assay, incorporating our gold-standard COVID PCR diagnostic test with an influenza A+B panel, which identifies individual infections or co-infections. This test is available under the FDA’s emergency use authorization (EUA) outlined for COVID-19 diagnostic testing.

Download the PDF
COVID-19 Antibody Testing cover

COVID-19 Antibody Test

The AccessDx COVID-19 Antibody tests are laboratory-based diagnostics designed to identify the presence of IgG antibodies from a patient’s blood sample. This test identifies individuals who have had previous exposure to the SARS-CoV-2 virus, even if they remained asymptomatic. Antibody tests are compliant with the FDA’s in-effect policy guidance for COVID-19 testing performed by CLIA-certified laboratories.

Download the PDF

Personalized Diagnostics

PGx cover

Pharmacogenomics and Personalized Medication Management (PGx)

AccessDx Pharmacogenomics solutions utilize the latest in high-quality evidence based-science to maximize clinical impact and empower clinical decision support. AccessDx Lab offers a range of panels and program designs to benefit combinatorial medication risk assessments, specialty medication analysis, and clinical research programs. When combined with the MedTek21 clinical decision support program, providers can seamlessly integrate pharmacogenomics within their clinical workflow and existing EMR platforms.

Download the PDF
Hereditary Cancer cover

Hereditary Cancer Testing (CGx)

The AccessDx Hereditary Cancer (CGx) screening assay analyzes causative variants involved in some of the most common hereditary cancers with relatively high population occurrences. This molecular diagnostics program enables clinical providers and patients to make proactive decisions about prevention options, lifestyle choices, and potential therapies.

Download the PDF

Infectious Disease Diagnostics

GI cover

Gastrointestinal Pathogen Panel (GI)

The AccessDx Gastrointestinal Pathogen Panel quickly identifies several enteropathogenic viruses, bacteria, and parasites responsible for gastroenteritis by utilizing multiplex quantitative Real-time PCR. It precisely detects the pathogens during single or coinfections and identifies antibiotic drug resistance in one single test. It also facilitates antibiotic stewardship by pinpointing situations for which antibiotics should be avoided.

Download the PDF

Influenza A+B Test (Flu)

The AccessDx Influenza (flu) A+B Test quickly identifies the A and B strains of the flu virus. This test is a high-quality, clinical-grade PCR test, which delivers accurate diagnoses quickly, allowing providers to initiate the best treatments sooner.

Download the PDF
Nail Pathogen cover

Nail Pathogen Panel (NPP)

With the AccessDx Nail Pathogen Panel, physicians can identify a fungal toenail infection quickly with the added benefit of species identification. The panel can detect both fungi and bacteria from the microbial nail flora.

Download the PDF
Respiratory pathogen panel

Respiratory Pathogen Panel (RPP)

The AccessDx Laboratory Respiratory Pathogen Panel rapidly detects and differentiates a wide range of viral and bacterial pathogens so effective treatment can begin sooner.

Download the PDF
UTI panel cover

Urinary Tract Infection Panel

Urinary tract infections (UTIs) are the most common infections requiring medical attention and a leading justification for antibiotic prescription. AccessDx molecular diagnostic test accurately detects uropathogens and improves treatment selection while preserving antibiotic stewardship. These enhancements in both speed and accuracy compared with traditional detection methods improve the clinical decisioning process, drive lower overall care costs and readmits, improve outcomes, and creating operational efficiencies for the healthcare team.

Download the PDF
Wound pathogen cover

Wound Pathogen Panel (WPP)

The AccessDx Laboratory Wound Pathogen Panel (WPP) rapidly establishes the microbiological profile of a sample and simultaneously reveals antibiotic resistance genes. This diagnostic uses a molecular-based analysis platform that provides enhanced precision and speed for species identification when compared to conventional cultures.

Download the PDF

Other Solutions

Advanced Toxicology Screening

Toxicology screens are typically used to identify chemicals, drugs, or toxins that may impact a patient’s health or plan of care. AccessDx Lab’s toxicology screening programs are molecular-based diagnostics that support both traditional urinalysis and simplified oral samples to rapidly identify the presence of target substances. Oral samples are especially useful for patients that are unable to urinate at the time of testing or for facilities that require gender-neutral specimen collection.

Download the PDF

Experience a New Standard
in Lab Diagnostics

Contact Us